Skip to content
Home/Companies/Biotech/Sitryx
Sitryx

Sitryx

Biotech·UK·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Sitryx?

Sitryx is currently owned by Oxford Science Enterprises through Oxford Science Enterprises Balance Sheet (2015 vintage), since 2023.

Hand-verified · updated 2026-07-16

Oxford Science Enterprises
Investor
Oxford Science Enterprises
Oxford Science Enterprises Balance Sheet · 2015 · Balance Sheet

Key facts

HQUK
SectorBiotech
StatusActive
Websitewww.sitryx.com

More from Oxford Science Enterprises Balance Sheet

Other portfolio companies in the same fund.

Allos
Allos
Active
AI/MLUK· 2026
Caudal Energy
Active
EnergyUK· 2026
Densix
Active
Deep TechUK· 2026
Marley Health
Marley Health
Active
HealthTechUK· 2026
Stateful Robotics
Stateful Robotics
Active
Deep TechUK· 2026
Alethio Therapeutics
Active
BiotechUK· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Sitryx

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Sitryx.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue